<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>The marine lipopeptide somocystinamide A <br /> triggers apoptosis caspase 8 <br /> Wolf Wrasidlo*&#226;&#8364;&#160;, Ainhoa Mielgo*&#226;&#8364;&#161;, Vicente A. Torres*&#226;&#8364;&#161;, Simone Barbero*&#226;&#8364;&#161;, Konstantin Stoletov*&#226;&#8364;&#161;, Takashi L. Suyama&#194;&#167;, <br /> Richard L. Klemke*&#226;&#8364;&#161;, William H. Gerwick*&#194;&#167;&#194;&#182;, Dennis A. Carson*&#226;&#8364;&#160;, Dwayne G. Stupack*&#226;&#8364;&#160;&#226;&#8364;&#161; <br /> &#226;&#8364;&#161;Department   Pathology, University California San Diego (UCSD) School Medicine, *Moores UCSD Cancer Center, 3855 Health Sciences Drive, <br /> La Jolla, CA 92093-0803; &#194;&#182;Skaggs School Pharmacy Pharmaceutical Sciences, University California San Diego, 9500 Gilman Drive, La Jolla, CA <br /> 92093; &#194;&#167;Scripps Institute Oceanography, 8602 La Jolla Shores Drive, La Jolla, CA 92037 <br />  <br /> Contributed Dennis A. Carson, December 26, 2007 (sent review November 27, 2007) <br />  <br /> Screening novel anticancer drugs chemical libraries isolated            property. Many malignant tumors maintain expression caspase 8, <br /> <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> marine organisms, identified lipopeptide somocysti-                suggesting attractive target tumor suppression (10). <br /> namide A (ScA) pluripotent inhibitor angiogenesis                  Importantly, ScA possesses intrinsically attractive chemical prop- <br /> tumor cell proliferation. The antiproliferative activity largely           erties, including unique readily synthesized structure the <br /> attributable induction programmed cell death. Sensitivity             capacity spontaneously incorporate lipid nanoplatforms <br /> ScA significantly increased cells expressing caspase 8,              retaining proapoptotic activity. It such <br /> whereas siRNA knockdown caspase 8 increased <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-5' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span>survival</span>                  properties asset delivery targeted nanoparticles, <br /> exposure ScA. ScA rapidly efficiently partitioned                  currently development clinical use. <br /> liposomes retaining antiproliferative activity. Consistent <br /> with induction apoptosis lipid compartment,                  Results <br /> noted accumulation aggregation ceramide treated cells                ScA Induces Apoptosis Selectively Caspase 8. In initial studies, we <br /> and subsequent colocalization caspase 8. Angiogenic endo-                 reported ScA isolated mixed assemblage L. majuscula/ <br /> thelial cells extremely sensitive ScA. Picomolar concentra-            Schizothrix species yielded modest cytotoxic effects a <br /> tions ScA disrupted proliferation endothelial tubule                    murine neuroblastoma cell line (11). Initial studies some- <br /> formation vitro. Systemic treatment zebrafish local treat-            limited relatively low abundance compound. <br /> ment chick chorioallantoic membrane ScA resulted                In continuing investigations, document freshly <br /> dose-dependent inhibition angiogenesis, topical treat-              isolated ScA shows potent antiproliferative activity a <br /> ment blocked tumor growth caspase-8-expressing tumors.                   number human tumor cells (Table 1). Microscopic examina- <br /> Together, results reveal unexpected mechanism action                 tion reveals loss proliferation associated a <br /> for unique lipopeptide suggest future development             &#226;&#8364;&#732;&#226;&#8364;&#732;blebbing&#226;&#8364;&#8482;&#226;&#8364;&#8482; morphology (Fig. 1 A B), biochemical <br /> and similar agents antiangiogenesis anticancer drugs.                   analysis revealed proteolytic processing cellular proteins, such <br />                                                                                caspase 8 poly(ADP-ribose) polymerase (PARP), are <br /> angiogenesis &#229;&#8230;&#169; cancer &#229;&#8230;&#169; nanoparticle                                           hallmark indicators apoptosis (Fig. 1C). <span id='am-2' about='protege:TO' typeof='owl:Thing'>To</span> determine <br />                                                                                caspase 8 expression account increased ScA <br />  <br /> M       assive efforts develop improved anticancer drugs have <br />         focused high-throughput screening large compound <br /> libraries. This is, part, relative lack success <br />                                                                                activity, examined ability ScA induce apoptosis in <br />                                                                                wild-type Jurkat cells deficient caspase 8. Compared <br />                                                                                wild-type cells, apoptosis dramatically decreased <br /> achieved date using structure-based drug design                  caspase-8-deficient Jurkat cells exposed ScA (Fig. 1D). <br /> tumor targets. However, noteworthy anticancer                  Extending studies, knocked expression caspase <br /> drugs presently used clinical practice natural products                 8 (&#226;&#172;&#8225;80%) using short-hairpin RNA (shRNA) approach in <br /> (such taxoids, vinca alkaloids, anthracyclines)                   A549 cell line 5-fold loss sensitivity ScA <br /> derivatives natural products (such etoposides) (1). There-               (Fig. 1E). Finally, tested NB7 neuroblastoma tumor cells, <br /> fore, continued analysis natural sources remains likely              deficient caspase 8 expression, matched <br /> reveal new unexpected compounds potential medical                     sister line, NB7C8, reconstituted physiological levels <br /> applications, supported prior successes             caspase 8 expression (12). In case, expression of <br /> but recent assessments biodiversity (2&#226;&#8364;&#8220;4).                          caspase 8 increased potency (IC50) ScA 50-fold (Fig. <br />    In respect, metabolites marine microorganisms provide             1F). The results implicate caspase 8 effector apoptosis <br /> a significant resource discovery novel, small molecules         ScA treatment. <br /> pharmaceutical biomedical applications (5, 6). Lyngbya majus-                 Caspase 8 effector death receptor (DR)-mediated <br /> cula particular extensively studied produced               apoptosis DR ligation appropriate agonist, which <br /> &#226;&#172;&#381;250 different compounds diverse structural features (7, 8).              triggers recruitment adaptor protein FADD and <br /> This diversity attributable fact major theme          subsequent formation death-inducing signaling complex <br /> in L. majuscula biochemistry relies production metabolites <br /> via polyketide synthases nonribosomal peptide synthetases <br />                                                                                Author contributions: W.W. A.M. contributed equally work; W.W., A.M., V.A.T., <br /> within specialized biosynthetic pathways (9). Here,            K.S., D.A.C., D.G.S. designed research; W.W., A.M., V.A.T., K.S. performed research; <br /> activity mechanism action lipopeptide derived L.              S.B., T.L.S., R.L.K., W.H.G. contributed new reagents/analytic tools; W.W., A.M., V.A.T., <br /> majuscula, somocystinamide A (ScA), potently induces apo-                 K.S., D.A.C., D.G.S. analyzed data; W.W., D.A.C., D.G.S. wrote paper. <br /> ptosis tumor angiogenic endothelial cells. Although ScA                 The authors declare conflict interest. <br />                                                                                                                                                                                APPLIED BIOLOGICAL <br />  <br />  <br />  <br />  <br /> initiates apoptosis intrinsic extrinsic pathways,         Freely available online PNAS open access option. <br />                                                                                                                                                                                     SCIENCES <br />  <br />  <br />  <br />  <br /> more sensitive pathway involves activation caspase 8,                 &#226;&#8364;&#160;Towhom correspondence addressed. E-mail: wwrasidlo@ucsd.edu, dcarson@ <br /> requires concentrations low nanomolar range below,               ucsd.edu, dstupack@ucsd.edu. <br /> initiate alterations cell membrane apoptosis. The selec-            This article contains supporting information online www.pnas.org/cgi/content/full/ <br /> tive activation caspase 8 pathway small molecule                0712198105/DC1. <br /> promising, currently used anticancer agents              &#194;&#169; 2008 The National Academy Sciences USA <br />  <br />  <br />  <br /> www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0712198105                                                     PNAS &#229;&#8230;&#169; February 19, 2008 &#229;&#8230;&#169; vol. 105 &#229;&#8230;&#169; no. 7 &#229;&#8230;&#169; 2313&#226;&#8364;&#8220;2318 <br />  Table 1. Activity ScA versus tumor cell lines <br /> Cell line                      Type                        IC50 <br />  <br /> Jurkat                  Leukemia                           3 nM <br /> CEM                     Leukemia                          14 nM <br /> A549                    Lung carcinoma                    46 nM <br /> Molt4                   T cell leukemia                   60 nM <br /> MCF-7                   Breast carcinoma                 210 nM <br /> NB7                     Neuroblastoma                    810 nM <br /> PC3                     Prostate carcinoma               970 nM <br /> M21                     Melanoma                         1.3 &#226;?&#174;M <br /> U266                    Myeloma                          5.8 &#226;?&#174;M <br />  <br />  <br />  <br /> (13). Accordingly, Jurkat cells lacking FADD protected <br /> from ScA-mediated killing (Fig. 1D), implicating DR- <br /> mediated killing process. However, NB7C8 cells are <br /> resistant DR-mediated killing (12), similarly A549 cells <br /> do undergo Fas-mediated apoptosis (ref. 14; unpub- <br /> lished results), cell lines sensitive to <br /> ScA-induced killing. In agreement results, the <br /> addition Fas agonist CH11 did cooperate ScA <br /> to promote cell death [see supporting information (SI)]. <br /> However, DR &#226;&#8364;&#732;&#226;&#8364;&#732;ligation&#226;&#8364;&#8482;&#226;&#8364;&#8482; strictly required apoptosis <br /> induced DRs; rather, appears ligand-mediated <br /> redistribution membrane components critical to <br /> trigger cell death (15&#226;&#8364;&#8220;17). <br />  <br /> ScA Partitions Phospholipids Alters Membrane Structure. <br /> The delivery drugs liposomes clinically relevant (18). <br /> Because ScA lipophilic compound (logP &#226;&#171;&#189; 10.3), assessed <br /> the capacity ScA partition liquid phase 100-nm <br /> liposomes (nanosomes). Remarkably, interchelation ScA <br /> within nanosomes essentially complete 30 min, <br /> with residual unincorporated drug detected (data shown). <br /> Testing liposome-borne ScA maintained cytotoxic <br /> activity, apoptosis induced treatment cells <br /> with ScA nanosomes mimicked treatments ScA &#226;&#8364;&#732;&#226;&#8364;&#732;free&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br /> compound (Fig. 2B). Treatment control, unloaded nano- <br /> somes effect cell viability. Together, results <br /> support potential future nanosome-based delivery ScA <br /> in vivo, implicating lipid compartment ScA- <br /> mediated cell death. <br />    In respect, known alterations cell lipid <br /> compartment promote caspase-mediated cell killing. For <br /> example, ceramide-enriched membrane domains promote <br /> DR clustering activation caspase 8 (17, 19, 20), whereas <br /> treatment arachidonic acid mediate caspase-3-               Fig. 1. ScA induces apoptosis selectively caspase-8-dependent mech- <br /> dependent cell death (21). Therefore, examined A549           anisms. (A) Treatment A549 cells 100 nM ScA induces blebbing <br /> cells evidence alteration lipid compartment      morphology, observed bright-field microscopy. (B) A549 cells were <br /> exposure ScA. Interestingly, observed accumulation,         fixed costained antibodies directed ceramide (red chan- <br /> and aggregation, cell surface ceramide (Fig. 2B, red chan-        nel). (Scale bars A B: 25 &#226;?&#174;M.) Arrows indicate regions blebbing. <br /> nel) absent cells treated diluent (our           The nuclear compartment visualized using DAPI stain DNA (blue <br /> unpublished results) treated arachidonic acid          channel). The assessments performed 2 h treatment 300 nM <br />                                                                      ScA. (C) Immunoblot analysis Jurkat cells performed treatment <br /> (control) (Fig. 2B). This result supported notion ScA <br />                                                                      100 nM ScA. Then, 25 &#226;?&#174;g cell lysates probed caspases 8, 3, <br /> acted alterations plasma membrane. To evaluate            9, PARP, actin (loading control) indicated. (D) Caspase <br /> whether observed alterations membrane lipid distribution          8-deficient (Casp 8&#226;&#171;&#186;), FADD-deficient (FADD&#226;&#171;&#186;), parental Jurkat cells <br /> corresponded interactions apoptotic effectors, par-       (Jurkat) incubated 50 300 nM 6 h analyzed the <br /> ticular caspase 8, examined aggregated         presence apoptotic cells FACS analysis DNA content. Results shown <br /> &#226;&#8364;&#732;&#226;&#8364;&#732;clusters&#226;&#8364;&#8482;&#226;&#8364;&#8482; ceramide membrane colocalized       mean standard error triplicate determinations. (E) A549 cells <br /> caspase (Fig. 2B, green channel; colocalization shown      subjected lentivirus-delivered shRNA-mediated knockdown caspase 8 <br /> yellow channel). The results supported notion ScA           treated scrambled shRNA lentivirus. Cells cultured in <br />                                                                      presence increasing doses ScA, indicated. Viability mea- <br /> partitions cell membranes, alters lipid compartment <br />                                                                      sured XTT assay 72 h normalized controls treated with <br /> and induces external death pathway susceptible cells.         drug. (F) Similarly, viability neuroblastoma cultures deficient in <br /> Although ceramide used reporter changes           caspase expression, reconstituted caspase 8 expression, deter- <br /> the organization lipid compartment, remains unclear        mined A549 cells above. Both experiments representative, <br /> which lipids (if any) directly contribute apoptosis. However,     point shown mean &#226;&#171;&#190; SE triplicate wells. <br />  <br />  <br /> 2314 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0712198105                                                                                Wrasidlo et al. <br />       A                        105                                                                                                 (20, 22, 23). We tested effect ScA treatment on <br />                                95                                                                                                 endothelial cells vitro vivo. Cultured endothelial cells <br />                                85 <br />          % C ell V iability <br />                                75                                                                                                 extremely sensitive ScA (Fig. 3A), IC50 the <br />                                65                                                                       NP                        picomolar range. In agreement results, that <br />                                55                                                                       ScA                       ScA potently blocked endothelial cell tube formation vitro <br />                                45                                                                       ScA NP <br />                                35                                                                                                 (Fig. 3B), suggesting ScA act endothelial and <br />                                25                                                                                                 tumor cells vivo. <br />                                15                                                                                                    To test this, examined systemic exposure to <br />                                 5 <br />                                -5                                                                                                 ScA blocked developmental angiogenesis zebrafish. During <br />                                     10 -9   10 -8         10 -7     10 -6         10 -5                                           development zebrafish, intersegmental vessels sprout and <br />                                                         D ose (M)                                                                 grow upwards dorsal aorta, tips join to <br />                                                                                                                                   form dorsal vein (Fig. 4A). In dose-dependent manner (Fig. <br />                                                                                                                                   4 B&#226;&#8364;&#8220;F), ScA blocked blood vessel growth angiogenesis, <br />       B                                                             C                                                             fish remained viable 24-h period <br />                                                                                                                                   study. Similarly, local introduction ScA chick <br />                                                                                                                                   chorioallantoic membrane potently blocked growth-factor- <br />                                                                                                                                   induced angiogenesis (Fig. 4G). The results demonstrate the <br />                                                                                                                                   sensitivity endothelial cells ScA vivo, agreement with <br />                                                                                                                                   observations vitro, indicate ScA acts an <br />                                                                                                                                   antiangiogenic agent. However, clear ScA <br />                                                                                                                                   act directly tumor cells vivo. <br />                                                                                                                                      To tested capacity ScA directly inhibit tumor growth <br />                                                                                                                                   vivo, neuroblastoma tumors expressing (or lacking) caspase 8 <br />                                                                                                                                   seeded chick chorioallantoic membrane, a <br />                                                                         &quot;M ono m er&quot; <br />  D                                                                                     N <br />                                                                                                                  NH A c <br />                                                                                                                                   tumor mass allowed establish 3 days. Tumors then <br />                                                                                            O                         SH           treated topically 100 pmol ScA allowed grow <br />                                                                                                                                   5 days harvested. In case, observed <br />                                                                               &quot;T ru nca ted&quot; <br />                                                                                                                      NH A c       inhibition tumor growth selectively caspase-8- <br />                                                                                            HN <br />  <br />                                                                                                 O                         S <br />                                                                                                                                   expressing tumor cells. The results that, addition an <br />            N <br />                                             NH A c                                                  O                         S <br />                                                                                                                                   antiangiogenic effect, low levels ScA act inhibit the <br />                                                                                             HN <br />                     O <br />                               O <br />                                                S <br />                                                     S <br />                                                                                                                        N H Ac     growth caspase-8-expressing tumor cells. <br />                    N <br />                                                                              L ipo pep tide only <br />                                               N H Ac <br />                                                                                                         N                         Discussion <br />                  S om o cys tina m id e A                                                                   O <br />                                                                                                                                   The genetic diversity world&#226;&#8364;&#8482;s oceans recently become <br />                                                                                                             O                     widely appreciated (2&#226;&#8364;&#8220;4, 24, 25). In particular, diversity of <br />                                                                          Altern ate Link er <br />                                                                                                         N <br />                                                                                                                                   biochemical matter arises unique previously unchar- <br />                                                                                        N                                          acterized metabolic pathways holds promise development of <br />                                                                                            O <br />                                                                                                                  O <br />                                                                                                                           X       new compounds treatment human malignancy. This study <br />                                                                                                                           Y <br />  <br />                                                                                        N <br />                                                                                            O <br />                                                                                                                                   focuses activity ScA, lipopeptide derived the <br />                                                                                                                                   cyanobacteria L. majuscula (26, 27). We ScA <br /> Fig. 2. ScA partitions lipid compartment. (A) ScA mixed                                                         selectively activates caspase-8-dependent cell death pathway. <br /> DOPE:cholesterol:DSPC:DSPE-mPEG form liposomes, described Mate-                                                          Interestingly, apoptosis occurs tumor lines normally <br /> rials Methods. ScA completely partitioned lipid nanosomes,                                                           resistant treatment DR agonists act caspase 8, which <br /> which effective diameter 109 nm polydispersity 0.205. A549                                                     particular tumors tend maintain <br /> cells cultured free ScA added DMSO diluent ScA incor-                                                        caspase 8 expression, likely ability fulfill <br /> porated nanosomes, cell viability assessed XTT assay                                                           nonapoptotic roles (10, 28), resistant DR-mediated <br /> described above. (B C) A549 cells stained anti-ceramide (red                                                        killing (29). Other natural products, including complex hetero- <br /> channel), DAPI (blue channel), anti-caspase 8 (green channel) 30 min after <br />                                                                                                                                   cycle gambogic acid (30) related kaurene diterpene (31), <br /> treatment 300 nM arachidonic acid, control lipid (B), 300 nM ScA (C). <br /> Colocalization green red channels shown merge (yellow <br />                                                                                                                                   activate caspase-8-dependent killing. Although gambogic acid <br /> signal). (D) A limited structure&#226;&#8364;&#8220;function analysis required elements                                                   structurally unrelated ScA acts distinct molecular <br /> ScA (shown left) activity performed. Derivatives ScA synthesized                                                     pathways (30), shared property caspase 8 activation is <br /> derived included &#226;&#8364;&#732;&#226;&#8364;&#732;monomeric&#226;&#8364;&#8482;&#226;&#8364;&#8482; form (with &#226;&#172;?0.1% activity) forms                                                          interesting, conceivable compounds could <br /> which disulfide replaced alternative linkers, showed                                                        function defensive adaptations (9). <br /> activity 50 &#226;?&#174;M. A &#226;&#8364;&#732;&#226;&#8364;&#732;truncated&#226;&#8364;&#8482;&#226;&#8364;&#8482; lipopeptide maintained disulfide                                                      ScA induces alterations plasma membrane lipid compart- <br /> linkage lacked activity 50 &#226;?&#174;M.                                                                                         ment, indicated clustering ceramide cell surface <br />                                                                                                                                   associated activation caspase 8 cell death. At micro- <br />                                                                                                                                   molar concentrations, ScA induce cell death caspase-8- <br /> it simply lipophilic nature ScA resulted in <br />                                                                                                                                   independent pathways, shown capacity induce apoptosis <br /> proapoptotic activity. ScA disulfide-linked lipopeptide <br /> dimer (Fig. 2C), parallel structure&#226;&#8364;&#8220;function studies                                                                    caspase-8-deficient cells. This finding agreement other <br /> found individual monomers retained essentially ability                                                                    lipid agents, ceramide, induce apoptosis via <br /> (&#226;&#172;?0.1% potency) induce apoptosis. Similarly, chemical                                                                          different actions (19, 32). Nonetheless, cytotoxic actions <br />                                                                                                                                   ScA nanomolar picomolar concentrations caspase-8- <br />                                                                                                                                                                                                            APPLIED BIOLOGICAL <br />  <br />  <br />  <br />  <br /> modification lipopeptide tail molecule or <br /> manipulations disulfide bond abrogated tumoricidal                                                                     dependent. Our results group cell lines examined two <br />                                                                                                                                                                                                                 SCIENCES <br />  <br />  <br />  <br />  <br /> activity compound. Thus, combination lipopep-                                                                       categories: sensitive lower nanomolar ranges <br /> tide disulfide moieties appears critical ScA activity.                                                                     near-micromolar concentrations are <br />                                                                                                                                   required induce cell death (Table 1). All sensitive <br /> Antiangiogenic Antitumoral Effects ScA. Angiogenic endo-                                                                   lines killed caspase-8-mediated pathways. However, we <br /> thelial cells susceptible apoptosis initiated caspase 8                                                                 expect metabolic pathways regulate lipid composition <br />  <br /> Wrasidlo et al.                                                                                                                                     PNAS &#229;&#8230;&#169; February 19, 2008 &#229;&#8230;&#169; vol. 105 &#229;&#8230;&#169; no. 7 &#229;&#8230;&#169; 2315 <br />                                                                                  Fig. 4.    Antiangiogenic antitumor activity ScA. (A&#226;&#8364;&#8220;F) Transgenic <br />                                                                                 Tg(fli1:EGFP) zebrafish embryos GFP expressed endothelial cells <br />                                                                                 incubated (A) increasing concentrations ScA: 80 nM <br />                                                                                 (B), 160 nM (C), 300 nM (D) 1.6 &#226;?&#174;M (E), 3 &#226;?&#174;M (F). Blood vessel morphology <br />                                                                                 recorded fluorescence microscopy. (G) Filter disks impregnated with <br />                                                                                 100 ng basic FGF placed chorioallantoic membrane 11-day- <br />                                                                                 old chicks induce angiogenesis absence presence ScA, shown. <br />                                                                                 After 72 h, disks removed vascularity underlying cho- <br />                                                                                 rioallantoic membrane determined direct counting branch points using <br />                                                                                 dissecting microscope. (H) NB7 neuroblastoma cells lacking caspase 8 (filled <br />                                                                                 bar) NB7C8 cells reconstituted caspase 8 expression (open bars) were <br /> Fig. 3. Endothelial cells highly sensitive ScA. (A) Human endothelial <br />                                                                                 seeded 10-day-old chick chorioallantoic membranes form tumors. <br /> cells incubated ScA decreasing concentrations, shown, and <br />                                                                                 After 72 h, ScA added topically growing tumor mass. Tumors were <br /> viability assessed XTT assay 72 h. Data shown mean &#226;&#171;&#190; SE <br />                                                                                 harvested resected day 8, mass (wet weight) determined. Data <br /> of triplicate wells representative experiment. (B) Human endothelial <br />                                                                                 shown mean &#226;&#171;&#190; SD (n &#226;&#171;&#189; 8 &#226;&#8364;&#8220;12). The mass NB7C8 significantly <br /> cells plated Matrigel-coated surfaces allowed form tubules for <br />                                                                                 decreased (P &#226;&#172;? 0.002). <br /> 48 h presence DMSO diluent (Top). When ScA added (Middle and <br /> Bottom) cell viability compromised, endothelial cell tube formation <br /> was disrupted dose-dependent manner. <br />                                                                                 protect disulfide bond moiety metabolic degradation after <br />                                                                                 administration vivo. Thus, nanosomes attractive candidate <br /> of plasma membrane act independent factors                preclinical delivery ScA. <br /> can modulate cell sensitivity ScA.                                              Synthesis ScA involves known organic chemistry reactions <br />    ScA contains disulfide bond anticipated reduced              accomplished approach. Currently, <br /> upon exposure inner leaflet plasma membrane.                      investigating distinct reaction schemes optimize <br /> However, clear covalent modification                   yield purity future large-scale production. Storage ScA <br /> membrane components ScA necessary activate (or inacti-                 inert dry atmosphere anticipated necessary avoid <br /> vate) ScA-mediated killing. ScA does represent uncommon                      eventual hydrolytic degradation unsaturated amide, but <br /> structure compounds isolated marine cyanobacteria,                   compound quite stable. Similarly, produc- <br /> containing disulfide moiety lipopeptide tails, cyto-              tion nanosomes involves assembly commercially <br /> toxic activity ScA requires lipopeptide disulfide moi-              available structural targeting components, occurs in <br /> eties initiate caspase-8-dependent death. Truncation                  quantitative yields standard liposome production techniques. <br /> lipopeptide, reduction substitution sulfhydryl bonds,              Thus, ScA represents active natural compound appears <br /> abrogated cytocidal activity ScA. However, ScA integrated                unencumbered issues complex synthesis upscaling <br /> into nanosomes maintained activity, suggesting alternative              commonly associated natural products. <br /> mechanism delivery ScA sequestered                       The optimization targetable nanoplatforms home to <br /> protected hydrophobic environment, par-                   specific tumor vascular beds rapidly proceeding (33). This <br /> ticularly desirable vivo applications, based ability           therapeutic approach benefit pro-drug ap- <br /> liposomes stabilize provide targeting function ScA. For            proaches drugs, ScA, limited <br /> example, interchelation nanosomes expected                   solubility aqueous media act directly plasma <br />  <br /> 2316 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0712198105                                                                                             Wrasidlo et al. <br />  membrane susceptible cells. Toxic relatively insoluble                              2000] ammonium salt (DSPE-mPEG) (in 1:1:1:0.16:0.16 molar ratio) chloroform <br /> drugs, taxols, advantages conferred nano-                              taken 30-ml glass culture tubes, dried stream nitrogen gas, and <br /> platform-mediated delivery. Similarly, expect ability                          vacuum-desiccated minimum 6 h remove residual organic solvent. <br />                                                                                            The dried lipid film hydrated sterile deionized water total volume of <br /> of ScA readily partition nanosome lipid component                            1 ml minimum 12 h. Liposomes vortexed 2&#226;&#8364;&#8220;3 min remove any <br /> is advantageous targeted delivery compound                              adhering lipid film sonicated bath sonicator (ULTRAsonik 28X) 2&#226;&#8364;&#8220;3 <br /> tumors. The targeted nanosome strategy overcomes issues                               min room temperature produce multilamellar vesicles (MLVs). MLVs then <br /> in terms solubility metabolism ScA circulation.                         sonicated Ti-probe (using Branson 450 Sonifier 100% duty cycle <br /> In turn, drugs ScA compete interior &#226;&#8364;&#732;&#226;&#8364;&#732;cargo&#226;&#8364;&#8482;&#226;&#8364;&#8482;                           25 W output power) ice bath 1&#226;&#8364;&#8220;2 min produce small unilamellar <br /> space designated soluble drug payloads. We speculate                              vesicles (SUVs) indicated formation clear translucent solution. The <br /> such approaches represent efficient design                            solution pressure-filtered sequence 200-nm 100-nm <br />                                                                                            nucelopore polycarbonate membranes obtain liposome nanoparticles 100 <br /> the delivery combination therapies. Given sensitivity of <br />                                                                                            nm polydispersity factor &#226;&#172;?0.1. <br /> proliferating endothelial cells ScA, likely targeted <br /> delivery cells vascular compartment promote                               Endothelial Cell Tube Formation. Next, 96-well plates coated 200 &#226;?&#174;l <br /> potent specific antiangiogenic response.                                               Matrigel stored 4&#194;&#176;C use. Human umbilical vein <br />                                                                                            endothelial cells (HUVECs) harvested, cell suspensions pre- <br /> Materials Methods                                                                      pared density 200,000 ml, added 100 &#226;?&#174;l plates. <br /> Confocal Microscopy. For confocal analysis, A549 cells seeded glass                ScA DMSO added 10 nM, 100 pM, 1 pM concen- <br /> coverslips, treated ScA, DMSO, arachidonic acid (controls) 1 0.1             trations 1% DMSO control. The plates incubated 37&#194;&#176;C under <br /> &#226;?&#174;M concentration 30 min 6 h. After treatment, cells fixed              standard incubator conditions, results observed microscopically <br /> 10 min room temperature 4% paraformaldehyde, washed twice                     tube formation. <br /> PBS, permeabilized 2 min room temperature 0.1% Triton PBS, <br /> and blocked 30 min sterile 2% BSA PBS. The staining performed              Zebrafish Experiments. Blood vessel formation zebrafish follows. <br /> at room temperature 2 h, mouse monoclonal anti-human ceramide                     Transgenic Tg(fli1:EGFP) zebrafish embryos purchased The Zebrafish <br /> (Alexis) rabbit anti-human caspase 8 (BD PharMingen) antibodies fol-                   Model Organism Database (www.zfin.org) reported ref. 35. Adult fish and <br /> lowed secondary goat anti-mouse Alexa Fluor 568 goat anti-rabbit                    embryos maintained according Zebrafish: A Practical Approach (36). ScA <br /> Alexa Fluor 488 antibodies (Invitrogen). The blue DNA binding dye TOPRO-3                  DMSO stock solution diluted directly water, zebrafish <br /> (Molecular Probes) added secondary antibodies. The                   intersegmental vessels imaged Nikon c1-si confocal microscope after <br /> cells washed times PBS different incubation                    times specified. Raw image datasets processed using Imaris 3D image <br /> steps, incubation secondary fluorescently labeled antibodies              analysis software (www.bitplane.com). All animal procedures conducted in <br /> was performed dark. All antibodies diluted PBS. Confocal                    accordance appropriate regulatory standards protocol S06008 <br /> images recorded Nikon Eclipse C1 confocal microscope.                            approved UCSD Institutional Animal Care Use Committee. <br />  <br /> Cell Lines. Cells cell lines maintained DMEM RPMI medium             Chick Chorioallantoic Membrane Studies. The chorioallantoic membrane stud- <br /> 1640 supplemented 10% FCS. The caspase-deficient NB7 neuroblastoma                    ies performed using 10-day-old chick embryos described ref. 37. <br /> cells described ref. 34. Caspase-8-deficient reconstituted Jurkat         For tumor studies, 5 &#226;&#171;&#187; 106 NB7 NB7C8 neuroblastoma tumor cells were <br /> cells provided Steve Hedrick (University California San Diego).              seeded chorioallantoic membranes 10-day-old embryos the <br /> Silencing caspase 8 gene expression A549 cells performed             tumor allowed develop day 18 (12). <br /> the use delivering shRNA lentiviral format. Briefly, 293 T cells were <br /> transfected caspase 8 (Open Biosystems) scrambled (Addgene) shRNAs              Western Blotting Analysis. Cells treated indicated extracts were <br /> pLKO.1 lentiviral vector, lentiviral packaging plasmids (PMLDL,              prepared lysis RIPA buffer (100 mM Tris, pH 7.5/150 mM NaCl/1 mM <br /> VSV-G, RSV-REV) using fugene6. The ratio target shRNAs packaging                EDTA/1% deoxycholate/1% Triton X-100/0.1% SDS/50 mM NaF/complete pro- <br /> plasmids shRNA/PMLDL/VSV-G/RSV-REV 10/10/6/4 &#226;?&#174;g. Lentiviral superna-                tease inhibitor; Roche Molecular Biochemicals) ice. Cell extracts (25 &#226;?&#174;g) <br /> tants 293 T cells harvested 48 h used infect A549 cells. Viral      resolved 8% SDS/PAGE, transferred nitrocellulose, probed with <br /> constructs incubated 24 h A549 cell lines replacing media             antibodies. Caspase 8 probed polyclonal antibody (Millipore) or <br /> with selective media containing puromycin (1 &#226;?&#174;g/ml). The suppression caspase            affinity-purified catalytic domain-specific antisera (C8 &#226;&#8364;&#8220;531) prepared at <br /> 8 verified Western blotting analysis.                                               UCSD. Caspase-3 (MAB4703, 1:500; Chemicon), caspase 9 (sc17784, 1:100; <br />                                                                                            Santa Cruz Biotechnology), actin (1:5,000; Sigma), PARP (sc556493, 1:500; <br /> Cytotoxicity Assay. Cytotoxicity ScA assessed using XTT cell prolif-         Santa Cruz Biotechnology) probed mouse monoclonal antibodies. <br /> eration assay. Briefly, cells plated 96-well plates (5,000 well)           Bound antibodies detected horseradish peroxidase-conjugated <br /> incubated overnight 37&#194;&#176;C allow attachment spreading. After 24 h,             secondary antibodies (BioRad) ECL (Pierce). <br /> ScA added DMSO stock, previously frozen &#226;&#171;&#186;80&#194;&#176;C, added directly <br /> from serial dilutions DMSO concentrations ranging 100 &#226;?&#174;M 100 fM.             FACS Analysis. Cell viability analyzed flow cytometry propidium <br /> After 72 h, XTT (Aldrich Chemicals) added final concentration 250 &#226;?&#174;g           iodide (PI) staining, described ref. 38. Briefly, treatment, cells <br /> per well. The plates incubated standard tissue culture conditions          harvested ice-cold PBS, washed times PBS 4&#194;&#176;C, resus- <br /> until control wells (DMSO) reached OD value 1.0 1.5.                 pended 10 &#226;?&#174;g/ml PI. The extent apoptosis determined plotting PI <br /> measured 450 nm microtiter plate reader. The cell viability&#226;&#8364;&#8220; drug                fluorescence versus forward-scatter parameter Cell Quest software. <br /> dilution profiles obtained sigma plots, drug concentrations that <br /> inhibited growth 50% calculated multiple runs (IC50).                         ACKNOWLEDGMENTS. We thank David Mikolon technical assistance. This <br />                                                                                            work supported National Cancer Institute Grants CA107263 (to D.G.S.) <br />                                                                                            CA097022 (to R.L.K.) National Cancer Institute Drug Discovery <br /> Preparation Liposomes. Cholesterol:1,2-dioleoyl-sn-glycero-3-phosphoeth-                Grant CA023100-23 (to D.A.C.). K.S. supported California Breast Cancer <br /> anolamine (DOPE):1,2-dioleoyl-sn-glycero-3-phosphocholine (DSPC):scA:1,2-                  Research Fellowship 11FB0088, A.M. supported grant the <br /> dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-                  Swiss National Foundation. <br />  <br />  <br />  1. Newman DJ, Cragg GM (2007) Natural products sources new drugs       6. Kim J, Park EJ (2002) Cytotoxic anticancer candidates natural resources. Curr Med <br />     25 years. J Nat Prod 70:461&#226;&#8364;&#8220; 477.                                                          Chem Anticancer Agents 2:485&#226;&#8364;&#8220;537. <br />                                                                                                                                                                                         APPLIED BIOLOGICAL <br />  <br />  <br />  <br />  <br />  2. Venter JC, et al. (2004) Environmental genome shotgun sequencing Sargasso        7. Van Wagoner R, Drummond AK, Wright JLC (2007) Biogenetic diversity cyanobac- <br />     Sea. Science 304:66 &#226;&#8364;&#8220;74.                                                                   terial metabolites. Adv Appl Microbio 61:89 &#226;&#8364;&#8220;217. <br />                                                                                                                                                                                              SCIENCES <br />  <br />  <br />  <br />  <br />  3. Yooseph S, et al. (2007) The Sorcerer II Global Ocean Sampling expedition: Expanding    8. Gerwick WH, Tan LT, Sitachitta N (2001) Nitrogen-containing metabolites marine <br />     universe protein families. PLoS Biol 5:e16.                                         cyanobacteria. The Alkaloids, ed Cordell G (Academic, San Diego), Vol 57, pp 75&#226;&#8364;&#8220;184. <br />  4. Rusch DB, et al. (2007) The Sorcerer II Global Ocean Sampling expedition: Northwest     9. Moore RE (1996) Cyclic peptides depsipeptides cyanobacteria: A review. J Ind <br />     Atlantic eastern tropical Pacific. PLoS Biol 5:e77.                                Microbiol 16:134 &#226;&#8364;&#8220;143. <br />  5. Fenical W, Sethna K, Lloyd GK (2002) Marine microorganisms developing resource    10. Barnhart BC, et al. (2004) CD95 ligand induces motility invasiveness apoptosis- <br />     drug discovery. Pharmaceutical News 489 &#226;&#8364;&#8220; 494.                                         resistant tumor cells. EMBO J 23:3175&#226;&#8364;&#8220;3185. <br />  <br />  <br />  <br /> Wrasidlo et al.                                                                                                    PNAS &#229;&#8230;&#169; February 19, 2008 &#229;&#8230;&#169; vol. 105 &#229;&#8230;&#169; no. 7 &#229;&#8230;&#169; 2317 <br />  11. Nogle LM, Gerwick WH (2002) Somocystinamide A, novel cytotoxic disulfide dimer               24. Giovannoni S, Stingl U (2007) The importance culturing bacterioplankton the <br />     Fijian marine cyanobacterial mixed assemblage. Org Lett 4:1095&#226;&#8364;&#8220;1098.                        &#226;&#8364;&#732;omics&#226;&#8364;&#8482; age. Nat Rev Microbiol 5:820 &#226;&#8364;&#8220; 826. <br /> 12. Stupack DG, et al. (2006) Potentiation neuroblastoma metastasis loss                  25. Giovannoni SJ, Stingl U (2005) Molecular diversity ecology microbial plankton. <br />     caspase-8. Nature 439:95&#226;&#8364;&#8220;99.                                                                       Nature 437:343&#226;&#8364;&#8220;348. <br /> 13. Peter ME, Krammer PH (2003) The CD95(APO-1/Fas) DISC beyond. Cell Death Differ             26. Moore RE (1981) Constituents blue-green algae. Mar Nat Prod: Chem Biol Perspect <br />     10:26 &#226;&#8364;&#8220;35.                                                                                         4:1&#226;&#8364;&#8220;52. <br /> 14. O&#226;&#8364;&#8482;Donnell DR, Milligan L, Stark JM (1999) Induction CD95 (Fas) apoptosis             27. Burja AM, Banaigs B, Abou-Mansour E, Grant Burgess J, Wright PC (2001) Marine <br />     respiratory epithelial cell cultures following respiratory syncytial virus infection. Virol-       cyanobacteria: A prolific source natural products. Tetrahedron 57:9347&#226;&#8364;&#8220;9377. <br />     ogy 257:198 &#226;&#8364;&#8220;207.                                                                              28. Helfer B, et al. (2006) Caspase-8 promotes cell motility calpain activity under <br /> 15. Muppidi JR, Siegel RM (2004) Ligand-independent redistribution Fas (CD95)                  nonapoptotic conditions. Cancer Res 66:4273&#226;&#8364;&#8220; 4278. <br />     lipid rafts mediates clonotypic T cell death. Nat Immunol 5:182&#226;&#8364;&#8220;189.                           29. Schimmer AD, et al. (2006) Identification small molecules sensitize resistant <br /> 16. Malorni W, Giammarioli AM, Garofalo T, Sorice M (2007) Dynamics lipid raft                      tumor cells tumor necrosis factor-family death receptors. Cancer Res 66:2367&#226;&#8364;&#8220; <br />     components lymphocyte apoptosis: The paradigmatic role GD3. Apoptosis                    2375. <br />     12:941&#226;&#8364;&#8220;949.                                                                                    30. Kasibhatla S, et al. (2005) A role transferrin receptor triggering apoptosis when <br /> 17. Elyassaki W, Wu S (2006) Lipid rafts mediate ultraviolet light-induced Fas aggregation             targeted gambogic acid. Proc Natl Acad Sci USA 102:12095&#226;&#8364;&#8220;12100. <br />     M624 melanoma cells. Photochem Photobiol 82:787&#226;&#8364;&#8220;792.                                        31. Kondoh M, et al. (2004) Kaurene diterpene induces apoptosis human leukemia cells <br /> 18. Perez-Lopez ME, Curiel T, Gomez JG, Jorge M (2007) Role pegylated liposomal                     partly caspase-8-dependent pathway. J Pharmacol Exp Ther 311:115&#226;&#8364;&#8220;122. <br />     doxorubicin (Caelyx) treatment relapsing ovarian cancer. Anticancer Drugs            32. Santana P, et al. (1996) Acid sphingomyelinase-deficient human lymphoblasts mice <br />     18:611&#226;&#8364;&#8220; 617.                                                                                       defective radiation-induced apoptosis. Cell 86:189 &#226;&#8364;&#8220;199. <br /> 19. Rotolo JA, et al. (2005) Caspase-dependent -independent activation acid                 33. Torchilin VP (2006) Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532&#226;&#8364;&#8220;1555. <br />     sphingomyelinase signaling. J Biol Chem 280:26425&#226;&#8364;&#8220;26434.                                       34. Teitz T, et al. (2000) Caspase 8 deleted silenced preferentially childhood <br /> 20. Erdreich-Epstein A, et al. (2002) Ceramide signaling fenretinide-induced endothelial            neuroblastomas amplification MYCN. Nat Med 6:529 &#226;&#8364;&#8220;535. <br />     cell apoptosis. J Biol Chem 277:49531&#226;&#8364;&#8220; 49537.                                                  35. Lawson ND, Weinstein BM (2002) In vivo imaging embryonic vascular development <br /> 21. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM (2000) Intracellular                     using transgenic zebrafish. Dev Biol 248:307&#226;&#8364;&#8220;318. <br />     unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 97:11280 &#226;&#8364;&#8220;             36. Nusslein-Volhard C, Dahm R, eds (2003) Zebrafish: A Practical Approach (Oxford Univ <br />     11285.                                                                                             Press, Oxford). <br /> 22. Erdreich-Epstein A, et al. (2000) Integrins &#226;?&#163;v&#226;?&#164;3 &#226;?&#163;v&#226;?&#164;5 expressed endothelium         37. Storgard C, Mikolon D, Stupack DG (2005) Angiogenesis assays chick CAM. <br />     high-risk neuroblastoma inhibition associated increased endoge-               Methods Mol Biol 294:123&#226;&#8364;&#8220;136. <br />     nous ceramide. Cancer Res 60:712&#226;&#8364;&#8220;721.                                                          38. Torres VA, et al. (2006) Caveolin-1 controls cell proliferation cell death sup- <br /> 23. Erdreich-Epstein A, et al. (2005) Endotheli <br /> </body></html>